256 Newsroom — Uganda's Digital News Infrastructure
Health

Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings - Endpoints News

Share
Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings - Endpoints News
Image · Endpoints.news

What the report says

Eli Lilly tests brenipatide for alcohol use disorder & depression; CASPR/UPMC trials Novo's Wegovy for addiction. GLP-1 drugs show promise beyond metabolic disorders.

Read the full report at Endpoints.news →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting